Found: 8
Select item for more details and to access through your institution.
SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231157641
- By:
- Publication type:
- Article
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 131, doi. 10.1007/s10120-023-01443-9
- By:
- Publication type:
- Article
Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2259, doi. 10.3390/cancers12082259
- By:
- Publication type:
- Article
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
First-Line Maintenance Treatment in Metastatic Colorectal Cancer (mCRC): Quality and Clinical Benefit Overview.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 470, doi. 10.3390/jcm10030470
- By:
- Publication type:
- Article
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article